Nutex Health Inc.
NUTX
$123.54
-$16.97-12.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 802.02% | -2,314.37% | 0.03% | 98.85% | -470.47% |
| Total Depreciation and Amortization | 6.19% | 9.70% | 8.28% | -10.60% | -1.33% |
| Total Amortization of Deferred Charges | 5.45% | 5.42% | -41.39% | 971.36% | -114.03% |
| Total Other Non-Cash Items | 272.51% | 124.30% | 271.63% | -109.39% | 4,051.40% |
| Change in Net Operating Assets | -12,136.41% | -123.16% | 115.00% | 130.02% | -447.90% |
| Cash from Operations | -99.21% | -48.80% | 334.63% | 271.77% | -190.24% |
| Capital Expenditure | 35.97% | -10.57% | 23.88% | -188.81% | 128.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 105.36% |
| Divestitures | -100.00% | 149.21% | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -47.90% | 78.95% | -73.12% | -184.72% | 123.92% |
| Total Debt Issued | -63.56% | 45.39% | -26.85% | -27.47% | 213.49% |
| Total Debt Repaid | -66.48% | -42.05% | 62.32% | 11.23% | -71.45% |
| Issuance of Common Stock | 171.33% | 385.58% | -96.73% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -54.57% | 3.43% | -- | -- | 46.70% |
| Cash from Financing | -609.29% | 64.59% | -120.91% | 245.29% | 8.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.54% | -43.51% | 34.95% | 265.90% | 18.61% |